DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Vomiting - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Vomiting (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient:

Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: maintenance dose

Lapatinib
    Dosage: arm b
    Administration route: Oral
    Indication: Breast Cancer

Lapatinib
    Dosage: arm c
    Administration route: Oral

Paclitaxel
    Indication: Breast Cancer



Possible Epirubicin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23

Patient: 48 year old female

Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-06

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-27



Possible Epirubicin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)

Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Epirubicin
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Taxotere
    Dosage: 4 cycles, total 3 courses, dose taken once daily
    Indication: Breast Cancer
    Start date: 2011-10-14
    End date: 2011-11-25

Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S



Possible Epirubicin side effects in

Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-18

Patient:

Reactions: Vomiting

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (500 mg/m2 (every three weeks) intravenous (not otherwise specified))
    Indication: Breast Cancer Stage III

Epirubicin
    Dosage: (100 mg/m2 (every three weeks) intravenous (not otherwise specified))
    Indication: Breast Cancer Stage III

Fluorouracil
    Dosage: (500 mg/m2 (every three weeks) intravenous bolus)
    Indication: Breast Cancer Stage III



Possible Epirubicin side effects in

Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-15

Patient:

Reactions: Vomiting

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (500 mg/m2 (every three weeks) intravenous (not otherwise specified)
    Indication: Inflammatory Carcinoma of Breast Stage III

Epirubicin
    Dosage: (100 mg/m2 (every three weeks) intravenous (not otherwise specified)
    Indication: Inflammatory Carcinoma of Breast Stage III

Fluorouracil
    Dosage: (500 mg/m2 (every three weeks) intravenous bolus)
    Indication: Inflammatory Carcinoma of Breast Stage III



Possible Epirubicin side effects in female

Reported by a individual with unspecified qualification from Germany on 2012-06-07

Patient: female

Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Epirubicin
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate



Possible Epirubicin side effects in female

Reported by a physician from Germany on 2012-05-18

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Epirubicin
    Dosage: 200 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

Fluorouracil
    Dosage: 100 mg, unk
    Start date: 2010-11-05
    End date: 2011-01-07

NO Treatment Received
    Dosage: no treatment
    Indication: Breast Cancer

Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol



Possible Epirubicin side effects in 38 year old female

Reported by a individual with unspecified qualification from United States on 2012-01-27

Patient: 38 year old female

Reactions: Confusional State, Vomiting, Gastrointestinal Toxicity, Neurological Decompensation, Nausea, Oesophageal Fistula, FAT Embolism, Pyrexia, Haematemesis, Grand MAL Convulsion, Cerebral Artery Embolism, Brain Oedema, Intracranial Pressure Increased, Heart Injury, Gastrointestinal Injury

Adverse event resulted in: death

Drug(s) suspected as cause:
Cisplatin
    Indication: Oesophageal Carcinoma

Epirubicin
    Indication: Oesophageal Carcinoma

Fluorouracil
    Indication: Oesophageal Carcinoma

Oxaliplatin
    Indication: Oesophageal Carcinoma



Possible Epirubicin side effects in female

Reported by a physician from Switzerland on 2011-11-28

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Vomiting, Nausea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 75mgm2 per day
    Indication: Neoplasm
    Start date: 2009-04-01
    End date: 2009-04-06

Pazopanib
    Dosage: 800mg per day
    Administration route: Oral
    Indication: Neoplasm
    Start date: 2009-03-30
    End date: 2009-04-05

Other drugs received by patient: Laxoberon; Emend; Folic Acid; Omeprazole; Acetaminophen



Possible Epirubicin side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-25

Patient: 38 year old female

Reactions: Confusional State, Fistula, Vomiting, Nausea, Neurological Decompensation, Gastrointestinal Toxicity, Pyrexia, Grand MAL Convulsion, AIR Embolism, Brain Oedema, Intracranial Pressure Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Cisplatin
    Dosage: two cycles given, consolidation therapy

Epirubicin

Epirubicin

Fluorouracil
    Dosage: continuous infusion

Fluorouracil
    Dosage: continuous infusion

Fluorouracil
    Dosage: two cycles given, consolidation therapy

Oxaliplatin
    Dosage: 2-hour duration

Oxaliplatin
    Dosage: 2-hour duration

Therapeutic Radiopharmaceuticals
    Dosage: 50 gy given in 28 fraction

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012